SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin - Quaterly Results

07 Feb 2024 Evaluate
The sales for the December 2023 quarter moved up 43.85% to Rs. 41157.50 millions as compared to Rs. 28611.10 millions during the corresponding quarter last year.The company almost doubled its revenue to Rs. 9164.40 millions  from Rs. 404.00 millions in the quarter ended December 2023.Operating Profit saw a handsome growth to 12405.00 millions from 2322.30 millions in the quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 41157.50 28611.10 43.85 112706.20 84225.60 33.81 112588.30 117716.70 -4.36
Other Income 231.60 222.10 4.28 765.00 440.60 73.63 912.60 1504.20 -39.33
PBIDT 12405.00 2322.30 434.17 28341.00 8564.40 230.92 11739.20 4261.30 175.48
Interest 113.60 307.50 -63.06 428.60 690.00 -37.88 984.40 734.70 33.99
PBDT 12291.40 2014.80 510.06 27912.40 7874.40 254.47 10754.80 3526.60 204.96
Depreciation 1451.80 1340.30 8.32 4347.10 4021.40 8.10 5483.40 5141.90 6.64
PBT 10839.60 674.50 1507.06 23565.30 3853.00 511.61 5271.40 -1615.30 -426.34
TAX 1675.20 270.50 519.30 4145.20 791.00 424.05 1019.30 271.70 275.16
Deferred Tax -170.90 142.90 -219.59 -4.70 86.30 -105.45 60.40 -306.30 -119.72
PAT 9164.40 404.00 2168.42 19420.10 3062.00 534.23 4252.10 -1887.00 -325.34
Equity 910.70 909.60 0.12 910.70 909.60 0.12 910.00 909.00 0.11
PBIDTM(%) 30.14 8.12 271.33 25.15 10.17 147.29 10.43 3.62 188.03

Lupin Share Price

2377.90 -81.85 (-3.33%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×